Asghar Zara, Jamshaid Talha, Sajid-Ur-Rehman Muhammad, Jamshaid Usama, Gad Heba A
Department of Pharmaceutics, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan.
Department of Pharmaceutics, Faculty of Pharmacy, Strasbourg University, 67084 Strasbourg, France.
Pharmaceutics. 2023 Oct 27;15(11):2537. doi: 10.3390/pharmaceutics15112537.
Miconazole nitrate (MCNR) is a BCS class II antifungal drug with poor water solubility. Although numerous attempts have been made to increase its solubility, formulation researchers struggle with this significant issue. Transethosomes are promising novel nanocarriers for improving the solubility and penetration of drugs that are inadequately soluble and permeable. Thus, the objective of this study was to develop MCNR-loaded transethosomal gel in order to enhance skin permeation and antifungal activity. MCNR-loaded transethosomes (MCNR-TEs) were generated using the thin film hydration method and evaluated for their zeta potential, particle size, polydispersity index, and entrapment efficiency (EE%). SEM, FTIR, and DSC analyses were also done to characterize the optimized formulation of MCNR-TEs (MT-8). The optimized formulation of MCNR-TEs was incorporated into a carbopol 934 gel base to form transethosomal gel (MNTG) that was subjected to ex vivo permeation and drug release studies. In vitro antifungal activity was carried out against through the cup plate technique. An in vivo skin irritation test was also performed on Wistar albino rats. MT-8 displayed smooth spherical transethosomal nanoparticles with the highest EE% (89.93 ± 1.32%), lowest particle size (139.3 ± 1.14 nm), polydispersity index (0.188 ± 0.05), and zeta potential (-18.1 ± 0.10 mV). The release profile of MT-8 displayed an initial burst followed by sustained release, and the release data were best fitted with the Korsmeyer-Peppas model. MCNR-loaded transethosomal gel was stable and showed a non-Newtonian flow. It was found that ex vivo drug permeation of MNTG was 48.76%, which was significantly higher than that of MNPG (plain gel) ( ≤ 0.05) following a 24-h permeation study. The prepared MCNR transethosomal gel exhibited increased antifungal activity, and its safety was proven by the results of an in vivo skin irritation test. Therefore, the developed transethosomal gel can be a proficient drug delivery system via a topical route with enhanced antifungal activity and skin permeability.
硝酸咪康唑(MCNR)是一种生物药剂学分类系统(BCS)II类抗真菌药物,水溶性较差。尽管人们已多次尝试提高其溶解度,但制剂研究人员仍在努力解决这一重大问题。传递体是一种很有前景的新型纳米载体,可用于改善难溶性和低渗透性药物的溶解度和渗透性。因此,本研究的目的是开发载有MCNR的传递体凝胶,以增强皮肤渗透和抗真菌活性。采用薄膜水化法制备了载有MCNR的传递体(MCNR-TEs),并对其zeta电位、粒径、多分散指数和包封率(EE%)进行了评估。还进行了扫描电子显微镜(SEM)、傅里叶变换红外光谱(FTIR)和差示扫描量热法(DSC)分析,以表征MCNR-TEs(MT-8)的优化制剂。将MCNR-TEs的优化制剂加入卡波姆934凝胶基质中,制成传递体凝胶(MNTG),并进行体外渗透和药物释放研究。通过杯碟法对其进行体外抗真菌活性研究。还对Wistar白化大鼠进行了体内皮肤刺激性试验。MT-8呈现出光滑的球形传递体纳米颗粒,具有最高的包封率(89.93±1.32%)、最低的粒径(139.3±1.14nm)、多分散指数(0.188±0.05)和zeta电位(-18.1±0.10mV)。MT-8的释放曲线显示出初始突释,随后是持续释放,释放数据最符合Korsmeyer-Peppas模型。载有MCNR的传递体凝胶稳定,呈现非牛顿流体特性。在24小时的渗透研究后发现,MNTG的体外药物渗透率为48.76%,显著高于普通凝胶(MNPG)(P≤0.05)。所制备的载有MCNR的传递体凝胶表现出增强的抗真菌活性,体内皮肤刺激性试验结果证明了其安全性。因此,所开发的传递体凝胶可以成为一种高效的局部给药系统,具有增强的抗真菌活性和皮肤渗透性。
Pharmaceuticals (Basel). 2024-4-24
Assay Drug Dev Technol. 2024-1
Pharmaceuticals (Basel). 2024-9-4
Pharmaceutics. 2024-8-1
Pharmaceutics. 2024-6-16
Pharmaceuticals (Basel). 2024-4-24
Pharmaceuticals (Basel). 2022-4-10
Pharmaceutics. 2020-9-9
Colloids Surf B Biointerfaces. 2020-9